The role of neutrophils in the event of intestinal inflammation

Current Opinion in Pharmacology

Volumn 9, Issue 6, 2009, Pages 697-701

  Mumy, Karen L ^a   McCormick, Beth A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; BAICALEIN; CD11B ANTIGEN; CD18 ANTIGEN; CD47 ANTIGEN; DECAY ACCELERATING FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLYCOPROTEIN P; HEPOXILIN A; HERMES ANTIGEN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN 2; PHOSPHOLIPASE A2; PROTEIN KINASE C;

BACTERIAL IMMUNITY; CYTOKINE RELEASE; DRUG TARGETING; ENTERITIS; ENZYME ACTIVATION; HUMAN; MICROBIAL IMMUNITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; DRUG DELIVERY SYSTEMS; ENTEROCOLITIS; HUMANS; IMMUNITY, CELLULAR; INFECTION; INTESTINAL MUCOSA; MODELS, BIOLOGICAL; NEUTROPHIL INFILTRATION; SIGNAL TRANSDUCTION;

EID: 70449462857     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.10.004     Document Type: Review

References (33)

1. Bainton D.F., Ullyot J.L., and Farquhar M.G. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 134 (1971) 907-934
2. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6 (2006) 173-182
3. Brinkmann V., and Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 5 (2007) 577-582. Important review that provides outstanding review on neutrophil production of neutrophil extracellular traps (NETs) that capture and kill pathogens.
4. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., and Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 303 (2004) 1532-1535
5. MacDermott R.P. Chemokines in the inflammatory bowel diseases. J Clin Immunol 19 (1999) 266-272
6. Eckmann L., and Kagnoff M.F. Cytokines in host defense against Salmonella. Microbes Infect 3 (2001) 1191-1200
7. Egesten A., Eliasson M., Olin A.I., Erjefalt J.S., Bjartell A., Sangfelt P., and Carlson M. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int J Colorectal Dis 22 (2007) 1421-1427
8. Phalipon A., and Sansonetti P.J. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?. Immunol Cell Biol 85 (2007) 119-129
9. Figueiredo J.F., Lawhon S.D., Gokulan K., Khare S., Raffatellu M., Tsolis R.M., Baumler A.J., McCormick B.A., and Adams L.G. Salmonella enterica Typhimurium SipA induces CXC-chemokine expression through p38MAPK and JUN pathways. Microbes Infect 11 (2009) 302-310
10. Varon C., Duriez A., Lehours P., Menard A., Laye S., Zerbib F., Megraud F., and Laharie D. Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut 58 (2009) 629-635
11. McCormick B.A., Hofman P.M., Kim J., Carnes D.K., Miller S.I., and Madara J.L. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol 131 (1995) 1599-1608
12. Kucharzik T., Hudson III J.T., Lugering A., Abbas J.A., Bettini M., Lake J.G., Evans M.E., Ziegler T.R., Merlin D., Madara J.L., et al. Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut 54 (2005) 1565-1572
13. Pace-Asciak C.R., and Martin J.M. Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets. Prostaglandins Leukot Med 16 (1984) 173-180
14. Laneuville O., Corey E.J., Couture R., and Pace-Asciak C.R. Hepoxilin A3 increases vascular permeability in the rat skin. Eicosanoids 4 (1991) 95-97
15. Sutherland M., Schewe T., and Nigam S. Biological actions of the free acid of hepoxilin A3 on human neutrophils. Biochem Pharmacol 59 (2000) 435-440
16. Mrsny R.J., Gewirtz A.T., Siccardi D., Savidge T., Hurley B.P., Madara J.L., and McCormick B.A. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc Natl Acad Sci U S A 101 (2004) 7421-7426
17. Mumy K.L., Bien J.D., Pazos M.A., Gronert K., Hurley B.P., and McCormick B.A. Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils. Infect Immun 76 (2008) 3614-3627
18. 3 secretion, and discusses the potential development of therapeutic strategies for the treatment of epithelial-associated inflammatory conditions by targeting MRP2.
19. McCormick B.A., Parkos C.A., Colgan S.P., Carnes D.K., and Madara J.L. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J Immunol 160 (1998) 455-466
20. Vedder N.B., and Harlan J.M. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 81 (1988) 676-682
21. Blake K.M., Carrigan S.O., Issekutz A.C., and Stadnyk A.W. Neutrophils migrate across intestinal epithelium using beta2 integrin (CD11b/CD18)-independent mechanisms. Clin Exp Immunol 136 (2004) 262-268
22. Hurley B.P., Sin A., and McCormick B.A. Adhesion molecules involved in hepoxilin A3-mediated neutrophil transepithelial migration. Clin Exp Immunol 151 (2008) 297-305
23. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
24. Yamamoto S., Kishimoto K., Arakawa T., Suzuki H., Nakamura M., Yoshimoto T., Takao T., Shimonishi Y., and Tanabe T. Arachidonate 12-lipoxygenases. Catalytic properties and regulation of the enzyme gene. Adv Exp Med Biol 407 (1997) 191-196
25. Yamamoto S., Suzuki H., Nakamura M., and Ishimura K. Arachidonate 12-lipoxygenase isozymes. Adv Exp Med Biol 447 (1999) 37-44
26. Yoshimoto T., and Yamamoto S. Arachidonate 12-lipoxygenase. J Lipid Mediat Cell Signal 12 (1995) 195-212
27. Kuhn H., and O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45 (2006) 334-356
28. Kuhn H., Walther M., and Kuban R.J. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat 68-69 (2002) 263-290
29. Balsinde J., Balboa M.A., Insel P.A., and Dennis E.A. Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39 (1999) 175-189
30. Diaz B.L., and Arm J.P. Phospholipase F A(2). Prostaglandins Leukot Essent Fatty Acids 69 (2003) 87-97
31. Zurawski D.V., Mitsuhata C., Mumy K.L., McCormick B.A., and Maurelli A.T. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect Immun 74 (2006) 5964-5976
32. Zurawski D.V., Mumy K.L., Badea L., Prentice J.A., Hartland E.L., McCormick B.A., and Maurelli A.T. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect Immun 76 (2008) 369-379
33. Zurawski D.V., Mumy K.L., Faherty C.S., McCormick B.A., and Maurelli A.T. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol Microbiol 71 (2008) 350-368